Approval · Notice of Compliance 9585 · 2008
CESAMET: Notice of Compliance 9585
Issued June 4, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9585
- Date
- June 4, 2008
- Company
- Valeant Canada LpLaval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 0.25 mg.
- Therapeutic class
- Antiemetic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CESAMET | 02312263 | Marketed |
Medicinal ingredients
- NABILONE 0.25 MG per CAP